docetaxel anhydrous has been researched along with desoxyepothilone b in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (desoxyepothilone b) | Trials (desoxyepothilone b) | Recent Studies (post-2010) (desoxyepothilone b) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 99 | 3 | 42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, TM; Dreicer, R; Fehrenbacher, L; Hannah, AL; Higano, CS; Hudes, G; Picus, J; Rarick, M; Saleh, M | 1 |
1 trial(s) available for docetaxel anhydrous and desoxyepothilone b
| Article | Year |
|---|---|
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Epothilones; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2007 |